Novel Strategies against Cancer: Dexibuprofen-Loaded Nanostructured Lipid Carriers

The aim of this work was to design innovative nanostructured lipid carriers (NLCs) for the delivery of dexibuprofen (DXI) as an antiproliferative therapy against tumoral processes, and overcome its side effects. DXI-NLC samples were prepared with beeswax, Miglyol 812 and Tween 80 using high-pressure...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiruchenthooran, Vaikunthavasan, Świtalska, Marta, Bonilla, Lorena, Espina, Marta, García, Maria Luisa, Wietrzyk, Joanna, Sánchez-López, Elena, Gliszczyńska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570096/
https://www.ncbi.nlm.nih.gov/pubmed/36232614
http://dx.doi.org/10.3390/ijms231911310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570096/
https://www.ncbi.nlm.nih.gov/pubmed/36232614
http://dx.doi.org/10.3390/ijms231911310

Ejemplares similares